Check eligibility for the current pharmacist-led programme, or join updates for the planned oral GLP-1 tablet pathway.
Consultation £49, care from £149 per month
Start assessment: /weight/eligibility?service=weight
Book consultation: /start?service=weight
Start eligibility for current pharmacist-led pathways. The oral GLP-1 tablet route is updates-only until the planned Q4 2026 launch.
Nuora's prescriptions are dispensed by Cornwells Chemists — a British pharmacy group whose dispensing lineage stretches back to 1835. A modern clinical service, dispatched under 190 years of pharmaceutical standards. Cold-chain where needed, discreet packaging, and the same GPhC oversight that every Cornwells pharmacy operates under.
Begin the assessment for current prescription or capsule pathways. The oral GLP-1 tablet route is a Q4 2026 updates list only; no tablet prescribing starts from this page today.
Current medication options · Ongoing pharmacist care
Start here if you want assessment for weight care available through Nuora now.
From £149/month
Prescription only. Subject to clinician approval.
Enhanced clinical monitoring · Pharmacist-led reviews
A more closely monitored pathway; higher-dose care is a separate tier if appropriate.
From £199/month; higher-dose tier shown in Pricing
Prescription only. Subject to clinician approval.
Orlistat 60 mg · Daily oral capsule
A current pharmacist-supervised oral capsule option for adults who may be suitable.
From £39/month
Planned oral GLP-1 tablet · Not prescribed today
Join launch updates; today’s assessment reviews current pharmacist-led pathways.
Important safety information — Some clinical care pathways can cause side effects, most commonly digestive symptoms. Read the full patient information leaflet before starting treatment, and report any side effect to the MHRA Yellow Card scheme. Treatment is only dispensed after a NUORA pharmacist has confirmed it is safe for you.
From your first message to your long-term plan adjustments, everything you need sits in your Nuora account. Chat, video, records, scheduling — no apps to install just for a prescription refill.
Always on. Every reply pharmacist-reviewed.
End-to-end encrypted. Booked in minutes.
Yours to read, share, or export.
Your next check-in, one tap away.
Continuous care. Every clinical decision pharmacist-reviewed.
A full clinical intake, not a five-question quiz.
A full clinical intake, not a five-question quiz.
Pharmacy partner support. Prescribing and supply decisions are recorded under pharmacy governance.
The eligibility assessment can be completed online, but no prescribing, dispensing, or supply decision is made until accountable GPhC-registered clinical cover is assigned, recorded, and shown in the patient record.
The named Superintendent Pharmacist must be recorded before any prescribing, dispensing, or supply decision is made.
A Responsible Pharmacist must be on duty before any clinical review can move into medicine supply.
The clinical lead owns protocol approval, escalation review, and launch readiness for each care pathway.
Medication (if prescribed), coaching, pharmacist reviews, delivery
Treatment cards show pathway starting points. The higher-support pathway can include a higher-dose pricing tier when a prescriber decides it is clinically appropriate.
One-off clinician review and prescribing assessment.
Check current eligibilityOngoing pricing depends on the prescribed care plan.
Check current eligibilityOngoing pricing depends on the prescribed care plan.
Check current eligibilityStill not sure? Our pharmacist team answer directly in the assessment.
Adults with BMI ≥27 (with comorbidities) or ≥30 seeking medical weight management.
Complete the clinical assessment online, text START WEIGHT to 07307 285 724, or WhatsApp us and the intake starts there. Prescribing, payment capture, and supply only proceed after accountable GPhC‑registered clinical review is assigned and recorded.
Was this page useful?
Your answer helps us improve the service journey.
